Although tumor mutational burden (TMB) in HRD tumors is generally not as high as in MMR-deficient tumors, HRD tumors have consistently been described to have a higher TMB as compared to HR-proficient tumors [18,19,20,21,22,23,24,25]. Here, MRC1 is linked to neoplasm.